@article{c1d394d96bf642e4b82c49bc29d1bfff,
title = "A new era of neoadjuvant treatment with Pertuzumab: Should the 10-lymph node guideline for axillary lymph node dissection in breast cancer be revised?",
keywords = "immunotherapy, neoadjuvant chemotherapy, pathologic complete response, perjeta",
author = "O'Leary, \{Michael P.\} and Beckord, \{Brian J.\} and Mock, \{Kyle E.\} and Venegas, \{Rose J.\} and Yeh, \{James J.\} and Dauphine, \{Christine E.\} and Ozao-Choy, \{Junko J.\}",
note = "Publisher Copyright: {\textcopyright} 2018 Wiley Periodicals, Inc.",
year = "2018",
month = dec,
doi = "10.1002/cnr2.1132",
language = "English",
volume = "1",
journal = "Cancer Reports",
issn = "2573-8348",
number = "4",
}